Scarica l'app Stockscreener
9.14
1.33%
0.12
Pre-mercato:
9.09
-0.05
-0.55%
Intellia Therapeutics Inc Azioni (NTLA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
14.33%
14.24
|
16.63 | 9.111 | 6.957 | 28.93 |
Operating Expenses
|
9.60%
124.24
|
137.43 | 153.88 | 146.00 | 142.94 |
| Benefits Costs and Expenses |
5.13%
124.24
|
130.96 | 153.88 | 146.00 | 136.37 |
| Costs And Expenses |
9.60%
124.24
|
137.43 | 153.88 | 146.00 | 142.94 |
| Operating Income/Loss |
8.95%
-110.00
|
-120.81 | -144.77 | -139.04 | -114.00 |
| Income/Loss From Continuing Operations Before Tax |
3.79%
-110.00
|
-114.33 | -144.77 | -146.97 | -107.44 |
| Income/Loss From Continuing Operations After Tax |
11.44%
-101.25
|
-114.33 | -135.71 | -146.97 | -107.44 |
|
Net Income/Loss
|
11.44%
-101.25
|
-114.33 | -135.71 | -146.97 | -107.44 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.22%
103.73
|
103.50 | 101.00 | 96.97 | 95.50 |
| Diluted Average Shares |
0.22%
103.73
|
103.50 | 101.00 | 96.97 | 95.50 |
| Basic Earnings Per Share |
10.91%
-0.98
|
-1.10 | -1.34 | -1.52 | -1.12 |
| Diluted Earnings Per Share |
10.91%
-0.98
|
-1.10 | -1.34 | -1.52 | -1.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):